Future Science Group

Listen to the top stories in infectious diseases this week, including novel CRISPR-based diagnostics, clinical trial in tuberculosis and the latest CDC approvals for the flu vaccine. Find the full stories: https://www.id-hub.com

Take a look at the top news stories of the week, including the measles vaccine and the sexual transmission of Zika.

In the final part of this 3-part panel discussion, our experts talk through the recent changes in the type of molecules and technologies the field are working with and what new technologies need to emerge to overcome current problems.

In part 2 of this 3-part panel discussion our panelists discuss the exciting topic of regulations as they consider the ICH M10 guidance and where they think the field might be going in the future.

In part 1 of this 3-part panel discussion highlight filmed in Barcelona our panel of experts discuss the issue of outsourcing and what priorities are need considering when making a purchasing

As part of our focus, we present this podcast where Dr Dominic Warrino discusses how immuno-oncology fits into the bioanalytical field and the technologies involved.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with David Jayne about colorectal surgery in regards to the development, application and evaluation of new surgical technologies.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Matthew Ellis at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about the future of proteomics and breast cancer research.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Michael Douek at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about novel techniques for breast surgery and reconstruction.

In this World AIDS Day interview we speak to Richard Koup, who was recently an author on a study reporting a trispecific antibody able to target 99% of HIV strains. www.id-hub.com

One of the major themes from this year’s SfN Neuroscience meeting (Washington DC, USA, 11–15 November 2017) was developments in neuromodulation techniques, including deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS). One study highlighted by the society came from Nicole Swann (University of California, San Francisco, LA, USA) and colleagues, who presented evidence that a novel implantable device can both provide DBS and record activity at the brain surface, providing feedback and causing the device to moderate stimulation level according to the patient’s levels of dyskinesia. Whilst at the conference, Lauren Pulling (Editor) sat down with Nicole to hear more about the study and its implications for patients and future research – you can listen to the podcast here. Plus, you can find our round-up of the biggest news from Neuroscience 2017 here: https://www.neuro-central.com/2017/11/20/sfn17-news-highlights-speaker-interviews-neuroscience-2017/

Whilst at SfN's Neuroscience 2017, Lauren Pulling sat down with Kijun Yoon, who discussed the latest updates in Zika research, including his work on a Zika virus protein that may cause microcephaly.

Whilst at Society for Neuroscience's annual meeting (Washington DC, USA, 11–15 November 2017), Lauren Pulling (Editor) sat down with Doris Doudet (University of British Columbia, Canada) to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson's disease rat model.

This week we had the pleasure of attending ‘Clearing the brain: protein clearance in neurodegenerative disease’, a 1-day symposium organized by the Leonard Wolfson Experimental Neurology Centre (LWENC) at University College London (UCL; London, UK). The event saw researchers and clinicians from across the world come together to share the latest research and debate the future of the field, with topics spanning perivascular clearance, fluid biomarkers, glymphatics, lymphatics, and a lively panel discussion. In this #NCTalks podcast, recorded at the event, we speak to Henrik Zetterberg, a Professor at the University of Gothenburg (Sweden) and UCL and one of the world’s leading experts in fluid biomarkers for neuronal injury and degeneration. In this podcast, he provides an update on the most promising blood-based biomarker candidates for neurodegenerative disease and tells us what he’s most excited to see in the coming years. Want to find out more about the event? Catch up on our highlights on our Twitter (@

Shalini Prasad and Sriram Muthukumar: non-invasive monitoring technologies by Future Science Group

Neuromodulatory techniques have risen in profile in recent years, with these groundbreaking therapies now being used to treat a vast range of conditions from Parkinson’s to pain, and obesity to depression. With these techniques now becoming more refined and more readily-available to patients, we spoke to Ali Rezai, a leading neurosurgeon and Director of The Ohio State University Neurological Institute (OH, USA). Dr Rezai has been involved in the pioneering use of brain pacemakers for treating Parkinson’s disease, depression, OCD and traumatic brain injury, and his current research focuses on developing neuromodulation therapies to treat migraine headaches, asthma, addictions, Alzheimer’s, obesity, post-traumatic stress disorders and autism. Listen to our latest NCTalks podcast with Dr Rezai to hear more about his work, how neuromodulation can be harnessed to treat ‘alternative’ conditions, and where he hopes the field will progress in the next decade. You can view more podcasts, plus the latest news and int

In this edition of NCTalks, we’ll be exploring the field of neuroregeneration as part of our latest Spotlight focus on Neuro Central. The limited capacity for repair in the nervous system represents a significant medical challenge - as the field works to address this, we’re learning more and more about innate regeneration, as well as how the regenerative process can be harnessed and exploited to treat neurodegenerative disease and facilitate repair following injury. In this podcast, Lauren Pulling (Editor) speaks to Dr Terry Burns, who practices and leads a research group at the Mayo Clinic in Rochester, Minnesota in the USA. His research group is developing regenerative strategies to optimize neurological function and quality of life for patients with brain tumors, neurological injuries and neurodegenerative diseases, with particular research focuses radiation-induced brain injury, microglial biology and cell-based regenerative therapies. Dr Burns tells us about his research, as well as the core challenges

In this podcast discover details of the TONIC trial which has yielded promising response rates in patients with metastatic triple-negative breast cancer treated with nivolumab after induction treatment.

Listen to this podcast to discover more about the UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer, data from which was presented at this years 2017 ESMO Congress (8–12th September, Madrid, Spain). You can view more podcasts plus the latest research, news and interviews at www.oncology-central.com

Listen to this podcast to discover more about CheckMate-153 study, data from which was presented at this years 2017 ESMO Congress (8–12th September, Madrid, Spain). You can view more podcasts plus the latest research, news and interviews at www.oncology-central.com